Status:

COMPLETED

Echocardiographic and Arterial Pressure Waveform Changes After Reducing Heart Rate With Esmolol in Septic Shock Patients

Lead Sponsor:

University of Roma La Sapienza

Conditions:

Tachycardia

Septic Shock

Eligibility:

All Genders

18+ years

Brief Summary

Clinical study suggests that beta-blockers by decreasing heart rate together with an increase in stroke volume do not negatively affect cardiac output allowing an economization of cardiac work and oxy...

Detailed Description

After 24-36 hours of initial hemodynamic stabilization, 44 septic shock patients with heart rate \> of 95 bpm and requiring norepinephrine to maintain mean arterial pressure (MAP) between 65 and 75 mm...

Eligibility Criteria

Inclusion

  • septic shock criteria
  • presence of heart rate \> 95 bpm.

Exclusion

  • Pregnancy
  • age \< 18

Key Trial Info

Start Date :

December 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

45 Patients enrolled

Trial Details

Trial ID

NCT02188888

Start Date

December 1 2013

End Date

June 1 2014

Last Update

August 7 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Anesthesiology and Intensive care of the University of Rome La Sapienza

Rome, Italy, 00161